ARTV

NASDAQArtiva Biotherapeutics, Inc. Common Stock
Calm Tide · 39Squeeze · Watch 33BullishSmart Money · No dataSocial · No data 0
$11.77
$-0.00 (-0.00%)
15-min delayed · Aug 26, 4:39 PMReal-time

Score summary

Strong Buy
Analyst Ratings
4Ratings
4 Buy0 Hold0 Sell
Tide Score
39
Calm Tide · stable · Bottom 30% of universe (3876)
Outlook39Calm Tide · stable · Bottom 24% of universe (3876)
Squeeze Score
33
Watch ·
  • Days to cover5.13
  • Short interest5.60% of float
  • Borrow rate99.85%
  • Short interest trend+0.40% (30d)
Trend
Bullish
Trending up — 4 of 8 indicators bullish
Recent Smart Money

Key statistics

Market Cap
$534.37M
52-week range
$2.28 – $13.39
416% from low
Day range
$12 – $12
Open $11.60
Volume
266k
vs 364k avg · 73%
P/E (TTM)
Fwd —
Earnings
Aug 27
1d · est $-0.64

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 4 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$40
4 Wall St 12-month targets
High
$41
Average
$39
Low
$35
$4$13$23$33$42HIGH$41MEDIAN$40LOW$35Feb ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 75/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Aug 27 (post-market, est EPS $-0.64) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.